BoltzGen: MIT’s Generative AI Redefines the Future of Drug Discovery Thanks to MIT’s BoltzGen, a generative AI capable of designing entirely new protein molecules, we may be entering an era of breakthrough treatments for the world’s toughest diseases. BoltzGen is setti... Biomedical research Biotechnology Drug discovery Generative AI Machine learning Open source Protein design